Quantcast

Latest diabetes mellitus Stories

2014-09-17 23:11:56

The Diabetes Protocol is a new product designed by Dr. Kenneth Pullman that reveals to people a highly advanced solution for treating diabetes for life. A detailed review on the site Vinamy.com indicates if this product is worth buying. Seattle, Wa (PRWEB) September 17, 2014 Diabetes currently has no cure. According to an article published by the Telegraph in August 2014, scientists made several breakthroughs in search for a “definite” cure for diabetes, but still failed. The article...

2014-09-17 12:27:46

SGLT-2 Inhibitors Will Be the Fastest-Growing Drug Class Over the 2013-2023 Forecast Period, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept. 17, 2014 /PRNewswire/ -- Decision Resources Group finds that as physicians continue to adopt a more individualized approach to patient care, branded type 2 diabetes therapies continue to experience increased use despite attempts by payer and reimbursement authorities to limit use of these more expensive drugs. As the robust...

2014-09-16 23:11:36

ADW Diabetes has teamed up with the Durham Diabetes Coalition by donating hundreds of blood glucose meters and other diabetes testing supplies to people in the local Durham area that do not have the resources to get these much needed supplies to maintain their health. Pompano Beach, FL. (PRWEB) September 16, 2014 ADW Diabetes has teamed up with the Durham Diabetes Coalition by donating hundreds of blood glucose meters and other diabetes testing supplies to people in the local Durham area...

2014-09-16 08:30:07

ACCU-CHEK Aviva Expert offers people with diabetes a new and easy way to simplify complex calculations to deliver precise insulin dosing advice INDIANAPOLIS, Sept. 16, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche's ACCU-CHEK(®) Aviva Expert system, the first and only blood glucose meter system with a built-in insulin calculator to be approved by the U.S. Food and Drug Administration (FDA), is now available by prescription. The device represents...

2014-09-16 08:27:23

Collaboration will create better understanding of Mobile Prescription Therapy BALTIMORE, Sept. 16, 2014 /PRNewswire/ -- The American Diabetes Association (ADA) Maryland Chapter and WellDoc®, a health care behavioral science and technology company, have announced the launch of a collaboration to empower people in Maryland with type 2 diabetes to take control of their diabetes by improving their day-to-day self-management. This announcement marks the beginning of the collaboration...

2014-09-15 12:24:19

Proven Benefit in Specific Subgroups Will Be a Key Market Access Lever in Crowded Drug Classes, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept. 15, 2014 /PRNewswire/ -- Decision Resources Group finds that as the type 2 diabetes treatment armamentarium continues to expand, increasing pressure to control expenditures will result in mounting prescribing constraints for premium-priced agents. Interviewed payers emphasize that although type 2 diabetes drugs will...

2014-09-12 23:05:54

Diet Doc’s specialized diet plans allow patients to take control of their own health and to prevent diabetes with the nation’s leading doctor-designed, medical weight loss solution Dallas, TX (PRWEB) September 12, 2014 Almost everyone knows that carrying extra weight, especially around the middle, has been linked to a variety of health conditions, including diabetes. However, not everyone knows that making simple lifestyle changes, reducing caloric intake and making healthier food...

2014-09-11 23:06:37

Transparency Market Research published a new report "Global and China Insulin Market: Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume) 2013 - 2019" to its report store. Albany, New York (PRWEB) September 11, 2014 According to a new market report published by Transparency Market Research "Global and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, Modern and Human Insulin) - Industry Analysis, Size,...

2014-09-11 16:28:19

- Oral presentation 9/19: interim Phase 3 results for ITCA 650 among patients with high baseline (HBL) HbA1c levels between 10-12% showed dramatic HbA1c reductions, even in patients with high HbA1c despite multi-drug therapy BOSTON, Sept. 11, 2014 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced its participation in the 50(th) Annual Meeting of the European Association for the Study of Diabetes (EASD), taking place in Vienna September 15 -19. Intarcia's lead product...

2014-09-11 16:26:05

Results from Phase 2b Clinical Study in Patients with Type 2 Diabetes Provide Evidence that SGLT1 inhibition with LX4211 Provides a Clinically Meaningful Benefit THE WOODLANDS, Texas, Sept. 11, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced a publication in the online edition of the American Diabetes Association's journal, Diabetes Care, entitled, "Greater Dose-Ranging Effects on A1C Levels Than on Glucosuria With LX4211, a Dual Inhibitor of Sodium...


Latest diabetes mellitus Reference Libraries

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (1 articles) »
Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'